Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis.

Although based on a small case series, our results may support the role of IS in better defining a subgroup of JIA subjects with stronger autoimmune features. The possible relevance of these results for therapeutic stratification remains to be explored.